Bio-Works Technologies AB (publ) (NGM: BIOWKS)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.830
0.00 (0.00%)
At close: Dec 20, 2024

Bio-Works Technologies AB Company Description

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden.

It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins.

The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.

Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Bio-Works Technologies AB (publ)
Country Sweden
Founded 2006
Industry Medicinal Chemicals and Botanical Products
Employees 36
CEO Lone Carlbom

Contact Details

Address:
Virdings allé 18
Uppsala, 754 50
Sweden
Phone 46 8 56 26 74 30
Website bio-works.com

Stock Details

Ticker Symbol BIOWKS
Exchange Nordic Growth Market
Fiscal Year January - December
Reporting Currency SEK
SIC Code 2833

Key Executives

Name Position
Lone Carlbom Chief Executive Officer
Jan Berglöf Co-Founder and Senior Advisor
Arne Hauge Chief Financial Officer and Head of Support Functions
Karsten Fjärstedt Chief Operating Officer
Helena Pahlm Senior Director of Global Quality
Silvia Hellstrom Head of Quality Assurance
Maria Åberg Head of Production
Anne Dyrdal Chief Commercial Officer